Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Foundation for Liver and Gastrointestinal Research is a Dallas-based non-profit organization dedicated to advancing clinical and basic science research in the fields of hepatology and gastroenterology. Operating in close collaboration with the Baylor Scott & White Health system, the foundation facilitates a wide array of clinical trials focusing on viral hepatitis, metabolic dysfunction-associated steatotic liver disease (MASLD), and liver transplantation. Its mission is to bridge the gap between laboratory discoveries and patient care by providing the infrastructure necessary for high-impact medical research. The foundation also supports educational initiatives for healthcare professionals to improve the diagnosis and management of chronic liver diseases. Through its partnerships, it remains at the forefront of developing innovative therapeutic strategies for complex digestive and liver disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Foundation for Liver and Gastrointestinal Research.